FENTICONAZOLE SUBSTIPHARM 600 mg, soft capsule vaginal capsule
Active ingredients: Fenticonazole, Fenticonazole nitrate
Commercialized according to BDPM
Soft capsulecapsulevaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FENTICONAZOLE SUBSTIPHARM 600 mg, capsule molle vaginale
- Pharmaceutical form
- capsule molle
- Route of administration
- vaginale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 1 capsule(s)
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Sept 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64636228CIP73018699CIP133400930186992Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NITRATE DE FENTICONAZOLEcapsule | 600 mg · une capsule | SA |
| FENTICONAZOLEcapsule | 527,1 mg · une capsule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.